Clinical trial
Anidulafungin Versus Fluconazole in the Treatment of Candidemia
NCT00058682 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00058682 |
|---|---|
| Title | Anidulafungin Versus Fluconazole in the Treatment of Candidemia |
| Official title | A Phase III, Double Blind, Randomized, Multi-Center Study of the Safety and Efficacy of Anidulafungin VS. Fluconazole in the Treatment of Patients With Candidemia and Other Forms of Invasive Candidiasis and Prevention of Complications |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Candida, Candidiasis |
| Intervention type | Drug |
| Interventions | Anidulafungin |
| Enrollment | 248 |
| Start date | Apr 1, 2003 |
| Completion | Jan 1, 2005 |
| First posted | Apr 11, 2003 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: